News Conference News ADA 2023 Oral, Daily Semaglutide Cuts Pounds in Nondiabetic Patients: OASIS 1 Shelley Wood June 29, 2023
News Conference News ADA 2023 Dramatic Weight Loss, Cardiometabolic Improvement With Retatrutide L.A. McKeown June 28, 2023
News Daily News ESH Upgrades Denervation, Details Comorbidities in New Hypertension Guideline Todd Neale June 27, 2023
News Daily News US Athlete’s Death Highlights Risk of Hypertensive Disorders of Pregnancy Michael O'Riordan June 19, 2023
News Conference News EuroPCR 2023 Renal Denervation: Exploring Its Potential Beyond Hypertension Todd Neale May 18, 2023
News Conference News EuroPCR 2023 Two New Renal Denervation Systems Look Good in Uncontrolled BP Todd Neale May 17, 2023
News Daily News Aortic Disease Deaths Tied to Modifiable Risk Factors, Japanese Data Confirm Caitlin E. Cox April 18, 2023
News Daily News Brain Areas Identified Linking High BP and Cognitive Impairment Todd Neale March 31, 2023
News Conference News ACC 2023 HALO: Baxdrostat No Better Than Placebo in Uncontrolled Hypertension Todd Neale March 08, 2023
News Conference News CRT 2023 Renal Denervation in Black Patients: SYMPLICITY HTN 3 Reassures at 36 Months Yael L. Maxwell February 28, 2023
News Opinion Editor's Corner ACC 2023 What’s Going to Be Hot at ACC/WCC 2023? Shelley Wood February 27, 2023
News Daily News Community Health Workers Boost BP Control in South Asian Immigrants Todd Neale February 24, 2023
News Daily News Cardiac Biomarkers May Help Refine HF Risk Stratification, Progression L.A. McKeown February 17, 2023
News Daily News Total Meals, Not Timing, Drives Long-term Body Weight Changes Todd Neale January 24, 2023
News Daily News Hypertension and Heavy Coffee Consumption a Bad Combo, Study Finds L.A. McKeown December 29, 2022
News Daily News Large Review Plumbs Possibilities, Pointlessness of Antioxidant Supplements Michael O'Riordan December 07, 2022
News Daily News Novel Aldosterone Synthase Inhibitor Drops BP: Top-line Phase II Results Todd Neale November 16, 2022
News Conference News AHA 2022 Endothelin Receptor Antagonist Effective in Resistant Hypertension: PRECISION Michael O'Riordan November 09, 2022
News Conference News AHA 2022 China Rural Intervention Still Reaping BP Control Wins at 3 Years L.A. McKeown November 09, 2022
News Conference News AHA 2022 SPYRAL HTN-ON MED Trial of Renal Denervation Misses Primary Endpoint Todd Neale November 09, 2022